These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

Doctors are currently using stem cells to treat a variety of medical conditions — and that list could soon become even larger ...

Our list of online ... brand-name semaglutide medications. The primary difference is the dosing and FDA approval. Wegovy is ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...

Those market dynamics will again be in focus when Novo reports results for its diabetes drug Ozempic and weight-loss ... get ...

and highly personalised treatment alternative. With continued research and refinement, the DT intervention may become a ...

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...